389 related articles for article (PubMed ID: 21788703)
1. Synergistic antifungal effect of lactoferrin with azole antifungals against Candida albicans and a proposal for a new treatment method for invasive candidiasis.
Kobayashi T; Kakeya H; Miyazaki T; Izumikawa K; Yanagihara K; Ohno H; Yamamoto Y; Tashiro T; Kohno S
Jpn J Infect Dis; 2011; 64(4):292-6. PubMed ID: 21788703
[TBL] [Abstract][Full Text] [Related]
2. In vitro synergy of pseudolaric acid B and fluconazole against clinical isolates of Candida albicans.
Guo N; Ling G; Liang X; Jin J; Fan J; Qiu J; Song Y; Huang N; Wu X; Wang X; Deng X; Deng X; Yu L
Mycoses; 2011 Sep; 54(5):e400-6. PubMed ID: 21910756
[TBL] [Abstract][Full Text] [Related]
3. The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents.
Shi W; Chen Z; Chen X; Cao L; Liu P; Sun S
FEMS Yeast Res; 2010 Nov; 10(7):885-93. PubMed ID: 20707818
[TBL] [Abstract][Full Text] [Related]
4. Lack of correlation of 24- vs. 48-h itraconazole minimum inhibitory concentrations with microbiological and survival outcomes in a guinea pig model of disseminated candidiasis.
Odabasi Z; Paetznick VL; Rodriguez JR; Chen E; Rex JH; Leitz GJ; Ostrosky-Zeichner L
Mycoses; 2010 Sep; 53(5):438-42. PubMed ID: 19500259
[TBL] [Abstract][Full Text] [Related]
5. Activated lactoferrin and fluconazole synergism against Candida albicans and Candida glabrata vaginal isolates.
Naidu AS; Fowler RS; Martinez C; Chen J; Tulpinski J
J Reprod Med; 2004 Oct; 49(10):800-7. PubMed ID: 15568403
[TBL] [Abstract][Full Text] [Related]
6. Reassessment of the in vitro synergistic effect of fluconazole with the non-steroidal anti-inflammatory agent ibuprofen against Candida albicans.
Arai R; Sugita T; Nishikawa A
Mycoses; 2005 Jan; 48(1):38-41. PubMed ID: 15679664
[TBL] [Abstract][Full Text] [Related]
7. Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry.
Pina-Vaz C; Rodrigues AG; Costa-de-Oliveira S; Ricardo E; Mårdh PA
J Antimicrob Chemother; 2005 Oct; 56(4):678-85. PubMed ID: 16115827
[TBL] [Abstract][Full Text] [Related]
8. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY
Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts.
Mondello F; De Bernardis F; Girolamo A; Salvatore G; Cassone A
J Antimicrob Chemother; 2003 May; 51(5):1223-9. PubMed ID: 12668571
[TBL] [Abstract][Full Text] [Related]
10. A D-octapeptide drug efflux pump inhibitor acts synergistically with azoles in a murine oral candidiasis infection model.
Hayama K; Ishibashi H; Ishijima SA; Niimi K; Tansho S; Ono Y; Monk BC; Holmes AR; Harding DR; Cannon RD; Abe S
FEMS Microbiol Lett; 2012 Mar; 328(2):130-7. PubMed ID: 22211961
[TBL] [Abstract][Full Text] [Related]
11. The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans.
Jin J; Guo N; Zhang J; Ding Y; Tang X; Liang J; Li L; Deng X; Yu L
Lett Appl Microbiol; 2010 Sep; 51(3):351-7. PubMed ID: 20681969
[TBL] [Abstract][Full Text] [Related]
12. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
Oz Y; Akşit F; Kiraz N; Kiremitçi A
Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of fluconazole on Candida albicans.
Abecia LC; Arévalo JM; López MJ
Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696
[TBL] [Abstract][Full Text] [Related]
14. Synergistic and drug-resistant reversing effects of diorcinol D combined with fluconazole against Candida albicans.
Li Y; Chang W; Zhang M; Li X; Jiao Y; Lou H
FEMS Yeast Res; 2015 Mar; 15(2):. PubMed ID: 25752309
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility and trailing growth of Candida albicans to fluconazole: results of a Korean multicentre study.
Lee MK; Kim HR; Kang JO; Kim MN; Kim EC; Kim JS; Kim JJ; Park YJ; Song W; Shin JH; Lee KM; Lee NY; Lee M; Lee WG; Lee CK; Lee HJ; Chang CL; Choi TY
Mycoses; 2007 Mar; 50(2):148-9. PubMed ID: 17305780
[TBL] [Abstract][Full Text] [Related]
16. Terpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle.
Zore GB; Thakre AD; Jadhav S; Karuppayil SM
Phytomedicine; 2011 Oct; 18(13):1181-90. PubMed ID: 21596542
[TBL] [Abstract][Full Text] [Related]
17. Effect of chemosensitizers on minimum inhibitory concentrations of fluconazole in Candida albicans.
Bulatova NR; Darwish RM
Med Princ Pract; 2008; 17(2):117-21. PubMed ID: 18287794
[TBL] [Abstract][Full Text] [Related]
18. Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans.
Calabrese EC; Castellano S; Santoriello M; Sgherri C; Quartacci MF; Calucci L; Warrilow AG; Lamb DC; Kelly SL; Milite C; Granata I; Sbardella G; Stefancich G; Maresca B; Porta A
J Antimicrob Chemother; 2013 May; 68(5):1111-9. PubMed ID: 23292344
[TBL] [Abstract][Full Text] [Related]
19. Repurposing of Ribavirin as an Adjunct Therapy against Invasive
Yousfi H; Cassagne C; Ranque S; Rolain JM; Bittar F
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307986
[TBL] [Abstract][Full Text] [Related]
20. Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole.
Bruzual I; Riggle P; Hadley S; Kumamoto CA
J Antimicrob Chemother; 2007 Mar; 59(3):441-50. PubMed ID: 17261564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]